Submucosal Injections Market Size, Share, Trends & Forecast
The Submucosal Injections Market was estimated at approximately USD 9.95 billion in 2023 and is projected to reach USD 42.9 billion by 2032, expanding at a CAGR of approximately 17.62% during 2025–2032. Rising gastrointestinal disorders, increasing adoption of minimally invasive procedures, and advancements in endoscopic technologies are contributing to market growth.
Submucosal injections are increasingly used during gastrointestinal procedures such as endoscopic mucosal resection and endoscopic submucosal dissection. Injecting materials into the submucosal layer can help elevate targeted tissue and support more precise endoscopic intervention.
The growing prevalence of gastrointestinal conditions is creating additional demand. Disorders such as gastroesophageal reflux disease, colorectal diseases, esophageal conditions, and other gastrointestinal abnormalities can require diagnostic and therapeutic procedures where submucosal injection technologies are useful.
Technological improvements in endoscopic equipment are also supporting adoption. High-resolution imaging and specialized injection needles can improve visualization and delivery accuracy during procedures.
Endoscopic injections currently represent the larger injection-type segment because of the increasing preference for minimally invasive approaches. Faster recovery and reduced procedural invasiveness are among the factors encouraging their use.
As gastrointestinal disease prevalence and demand for minimally invasive treatment continue to increase, manufacturers are expected to focus on innovative formulations, delivery systems, and injection technologies.